A Designed Angiopoietin-1 Variant, Dimeric CMP-Ang1 Activates Tie2 and Stimulates Angiogenesis and Vascular Stabilization in N-glycan Dependent Manner

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Oh, Nuri ^a   Kim, Kangsan ^a   Jin Kim, Soo ^a   Park, Intae ^a   Lee, Jung Eun ^a   Suk Seo, Young ^b   Joo An, Hyun ^b   Min Kim, Ho ^a   Young Koh, Gou ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; HYBRID PROTEIN; MATRILIN; POLYSACCHARIDE; PROTEIN KINASE B;

AGONISTS; ANGIOGENESIS; ANIMAL; CAPILLARY PERMEABILITY; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; GENETICS; GLYCOSYLATION; HUMAN; METABOLISM; MOLECULAR MODEL; MOUSE; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SIGNAL TRANSDUCTION;

ANGIOPOIETIN-1; ANIMALS; CAPILLARY PERMEABILITY; CELL LINE; ENDOTHELIAL CELLS; GLYCOSYLATION; HUMANS; MATRILIN PROTEINS; MICE; MODELS, MOLECULAR; NEOVASCULARIZATION, PHYSIOLOGIC; POLYSACCHARIDES; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, TIE-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 84945183684     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15291     Document Type: Article

References (37)

1. Davis, S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169 (1996).
2. Augustin, H. G., Koh, G. Y., Thurston, G., Alitalo, K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat. Rev. Mol. Cell Bio. 10, 165-177 (2009).
3. Koh, G. Y. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol. Med. 19, 31-39 (2013).
4. Thurston, G. et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511-2514 (1999).
5. Suri, C. et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180 (1996).
6. Arita, Y. et al. Myocardium-derived angiopoietin-1 is essential for coronary vein formation in the developing heart. Nat. Commun. 5, doi: 10.1038/ncomms5552 (2014).
7. Jeansson, M. et al. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121, 2278 (2011).
8. Procopio, W. N., Pelavin, P. I., Lee, W. M., Yeilding, N. M. Angiopoietin-1 and-2 coiled coil domains mediate distinct homooligomerization patterns, but fibrinogen-like domains mediate ligand activity. J. Biol. Chem. 274, 30196-30201 (1999).
9. Davis, S. et al. Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat. Struct. Mol. Biol. 10, 38-44 (2002).
10. Kim, K.-T. et al. Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J. Biol. Chem. 280, 20126-20131 (2005).
11. Cho, C.-H. et al. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc. Natl. Acad. Sci. USA. 101, 5547-5552 (2004).
12. Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60 (1997).
13. Cho, C.-H. et al. Designed angiopoietin-1 variant, COMP-Ang1, protects against radiation-induced endothelial cell apoptosis. Proc. Natl. Acad. Sci. USA. 101, 5553-5558 (2004).
14. Barton, W. A. et al. Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat. Struct. Mol. Biol. 13, 524-532 (2006).
15. Yu, X. et al. Structural basis for angiopoietin-1-mediated signaling initiation. Proc. Natl. Acad. Sci. USA. 110, 7205-7210 (2013).
16. Dames, S. A., Kammerer, R. A., Wiltscheck, R., Engel, J., Alexandrescu, A. T. NMR structure of a parallel homotrimeric coiled coil. Nat. Struct. Mol. Biol. 5, 687-691 (1998).
17. Haudenschild, D. R., Tondravi, M. M., Hofer, U., Chen, Q., Goetinck, P. F. The Role of Coiled-coil ?-Helices and Disulfide Bonds in the Assembly and Stabilization of Cartilage Matrix Protein Subunits. J. Biol. Chem. 270, 23150-23154 (1995).
18. Kim, H.-Z., Jung, K., Kim, H. M., Cheng, Y., Koh, G. Y. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 receptor and stimulates angiogenesis. BBA-Mole. Cell Res. 1793, 772-780 (2009).
19. Fukuhara, S. et al. Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat. Cell Biol. 10, 513-526 (2008).
20. Saharinen, P. et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat. Cell Biol. 10, 527-537 (2008).
21. Hwang, S.-J. et al. Expression and purification of recombinant human angiopoietin-2 produced in Chinese hamster ovary cells. Protein Expres. Purif. 39, 175-183 (2005).
22. Link, T. et al. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium. J. Biotechnol. 110, 51-62 (2004).
23. Brooks, S. A. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins. Expert Rev. Proteomic. 3, 345-359 (2006).
24. Croset, A. et al. Differences in the glycosylation of recombinant proteins expressed in HEK and CHO cells. J. Biotechnol. 161, 336-348 (2012).
25. Cho, C.-H. et al. Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ. Res. 97, 86-94 (2005).
26. Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat. Med. 6, 460-463 (2000).
27. Mammoto, T. et al. Angiopoietin-1 requires p190 RhoGAP to protect against vascular leakage in vivo. J. Biol. Chem. 282, 23910-23918 (2007).
28. Anisimov, A. et al. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis. Circulation 127, 424-434 (2013).
29. Elliott, S. et al. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat. Biotechnol. 21, 414-421 (2003).
30. Lee, J.-E. et al. Novel Glycosylated VEGF Decoy Receptor Fusion Protein, VEGF-Grab, Efficiently Suppresses Tumor Angiogenesis and Progression. Mol. Cancer Ther. 14, 470-479 (2014).
31. Straumann, N., Wind, A., Leuenberger, T., Wallimann, T. Effects of N-linked glycosylation on the creatine transporter. Biochem. J. 393, 459-469 (2006).
32. Dietmair, S. et al. A multi-omics analysis of recombinant protein production in Hek293 cells. PLoS one 7, e43394 (2012).
33. Butler, M., Spearman, M. The choice of mammalian cell host and possibilities for glycosylation engineering. Curr. Opin. Biotech. 30, 107-112 (2014).
34. Kim, S. H., Lee, G. M. Functional expression of human pyruvate carboxylase for reduced lactic acid formation of Chinese hamster ovary cells (DG44). Appl. Microbiol. Biot. 76, 659-665 (2007).
35. Booth, D. S., Avila-Sakar, A., Cheng, Y. Visualizing proteins and macromolecular complexes by negative stain EM: from grid preparation to image acquisition. J. Vis. Exp. 58, doi: 10.3791/3227 (2011).
36. Um, J. W. et al. Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. Nat. Commun. 5, doi: 10.1038/ncommas6423 (2014).
37. Oh, M. J. et al. Analytical platform for glycomic characterization of recombinant erythropoietin biotherapeutics and biosimilars by MS. Bioanalysis 5, 545-559 (2013).